Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, Status and Forecast 2020-2026

Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate Cancer Nuclear Medicine Diagnostics Revenue
1.4 Market Analysis by Type
1.4.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 SPECT
1.4.3 PET
1.5 Market by Application
1.5.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Prostate Cancer Nuclear Medicine Diagnostics Industry Impact
1.6.1 How the Covid-19 is Affecting the Prostate Cancer Nuclear Medicine Diagnostics Industry
1.6.1.1 Prostate Cancer Nuclear Medicine Diagnostics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Prostate Cancer Nuclear Medicine Diagnostics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Prostate Cancer Nuclear Medicine Diagnostics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Prostate Cancer Nuclear Medicine Diagnostics Market Perspective (2015-2026)
2.2 Prostate Cancer Nuclear Medicine Diagnostics Growth Trends by Regions
2.2.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prostate Cancer Nuclear Medicine Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Prostate Cancer Nuclear Medicine Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Prostate Cancer Nuclear Medicine Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Market Size
3.1.1 Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Concentration Ratio
3.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Prostate Cancer Nuclear Medicine Diagnostics Revenue in 2019
3.3 Prostate Cancer Nuclear Medicine Diagnostics Key Players Head office and Area Served
3.4 Key Players Prostate Cancer Nuclear Medicine Diagnostics Product Solution and Service
3.5 Date of Enter into Prostate Cancer Nuclear Medicine Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Prostate Cancer Nuclear Medicine Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Type (2021-2026)
5 Prostate Cancer Nuclear Medicine Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020)
5.2 Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size (2015-2020)
6.2 Prostate Cancer Nuclear Medicine Diagnostics Key Players in North America (2019-2020)
6.3 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020)
6.4 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size (2015-2020)
7.2 Prostate Cancer Nuclear Medicine Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020)
7.4 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Prostate Cancer Nuclear Medicine Diagnostics Market Size (2015-2020)
8.2 Prostate Cancer Nuclear Medicine Diagnostics Key Players in China (2019-2020)
8.3 China Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020)
8.4 China Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size (2015-2020)
9.2 Prostate Cancer Nuclear Medicine Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020)
9.4 Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size (2015-2020)
10.2 Prostate Cancer Nuclear Medicine Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Prostate Cancer Nuclear Medicine Diagnostics Market Size (2015-2020)
11.2 Prostate Cancer Nuclear Medicine Diagnostics Key Players in India (2019-2020)
11.3 India Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020)
11.4 India Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Prostate Cancer Nuclear Medicine Diagnostics Market Size (2015-2020)
12.2 Prostate Cancer Nuclear Medicine Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Blue Earth Diagnostics
13.1.1 Blue Earth Diagnostics Company Details
13.1.2 Blue Earth Diagnostics Business Overview and Its Total Revenue
13.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Introduction
13.1.4 Blue Earth Diagnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020))
13.1.5 Blue Earth Diagnostics Recent Development
13.2 PETNET Solutions
13.2.1 PETNET Solutions Company Details
13.2.2 PETNET Solutions Business Overview and Its Total Revenue
13.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Introduction
13.2.4 PETNET Solutions Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
13.2.5 PETNET Solutions Recent Development
13.3 Cardinal Health
13.3.1 Cardinal Health Company Details
13.3.2 Cardinal Health Business Overview and Its Total Revenue
13.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Introduction
13.3.4 Cardinal Health Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
13.3.5 Cardinal Health Recent Development
13.4 Lantheus Medical Imaging
13.4.1 Lantheus Medical Imaging Company Details
13.4.2 Lantheus Medical Imaging Business Overview and Its Total Revenue
13.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Introduction
13.4.4 Lantheus Medical Imaging Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
13.4.5 Lantheus Medical Imaging Recent Development
13.5 Jubilant Pharma
13.5.1 Jubilant Pharma Company Details
13.5.2 Jubilant Pharma Business Overview and Its Total Revenue
13.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
13.5.4 Jubilant Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
13.5.5 Jubilant Pharma Recent Development
13.6 NCM-USA
13.6.1 NCM-USA Company Details
13.6.2 NCM-USA Business Overview and Its Total Revenue
13.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Introduction
13.6.4 NCM-USA Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
13.6.5 NCM-USA Recent Development
13.7 Progenics Pharma
13.7.1 Progenics Pharma Company Details
13.7.2 Progenics Pharma Business Overview and Its Total Revenue
13.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
13.7.4 Progenics Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
13.7.5 Progenics Pharma Recent Development
13.8 Telix Pharma
13.8.1 Telix Pharma Company Details
13.8.2 Telix Pharma Business Overview and Its Total Revenue
13.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
13.8.4 Telix Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
13.8.5 Telix Pharma Recent Development
13.9 ImaginAb
13.9.1 ImaginAb Company Details
13.9.2 ImaginAb Business Overview and Its Total Revenue
13.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Introduction
13.9.4 ImaginAb Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
13.9.5 ImaginAb Recent Development
13.10 Theragnostics
13.10.1 Theragnostics Company Details
13.10.2 Theragnostics Business Overview and Its Total Revenue
13.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Introduction
13.10.4 Theragnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
13.10.5 Theragnostics Recent Development
13.11 Novartis
10.11.1 Novartis Company Details
10.11.2 Novartis Business Overview and Its Total Revenue
10.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Introduction
10.11.4 Novartis Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
10.11.5 Novartis Recent Development
13.12 Alliance Medical
10.12.1 Alliance Medical Company Details
10.12.2 Alliance Medical Business Overview and Its Total Revenue
10.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Introduction
10.12.4 Alliance Medical Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
10.12.5 Alliance Medical Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Prostate Cancer Nuclear Medicine Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Prostate Cancer Nuclear Medicine Diagnostics Revenue
Table 3. Ranking of Global Top Prostate Cancer Nuclear Medicine Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of SPECT
Table 6. Key Players of PET
Table 7. COVID-19 Impact Global Market: (Four Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Prostate Cancer Nuclear Medicine Diagnostics Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Prostate Cancer Nuclear Medicine Diagnostics Players to Combat Covid-19 Impact
Table 12. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Regions (2015-2020)
Table 16. Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Prostate Cancer Nuclear Medicine Diagnostics Market Growth Strategy
Table 22. Main Points Interviewed from Key Prostate Cancer Nuclear Medicine Diagnostics Players
Table 23. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Players (2015-2020)
Table 25. Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Nuclear Medicine Diagnostics as of 2019)
Table 26. Global Prostate Cancer Nuclear Medicine Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Prostate Cancer Nuclear Medicine Diagnostics Product Solution and Service
Table 29. Date of Enter into Prostate Cancer Nuclear Medicine Diagnostics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Share by Type (2015-2020)
Table 33. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Type (2021-2026)
Table 34. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Share by Application (2015-2020)
Table 35. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Prostate Cancer Nuclear Medicine Diagnostics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Prostate Cancer Nuclear Medicine Diagnostics Market Share (2019-2020)
Table 39. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2015-2020)
Table 41. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2015-2020)
Table 43. Europe Key Players Prostate Cancer Nuclear Medicine Diagnostics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Prostate Cancer Nuclear Medicine Diagnostics Market Share (2019-2020)
Table 45. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2015-2020)
Table 47. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2015-2020)
Table 49. China Key Players Prostate Cancer Nuclear Medicine Diagnostics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Prostate Cancer Nuclear Medicine Diagnostics Market Share (2019-2020)
Table 51. China Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 52. China Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2015-2020)
Table 53. China Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 54. China Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2015-2020)
Table 55. Japan Key Players Prostate Cancer Nuclear Medicine Diagnostics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Prostate Cancer Nuclear Medicine Diagnostics Market Share (2019-2020)
Table 57. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2015-2020)
Table 59. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Prostate Cancer Nuclear Medicine Diagnostics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Prostate Cancer Nuclear Medicine Diagnostics Market Share (2019-2020)
Table 63. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2015-2020)
Table 65. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2015-2020)
Table 67. India Key Players Prostate Cancer Nuclear Medicine Diagnostics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Prostate Cancer Nuclear Medicine Diagnostics Market Share (2019-2020)
Table 69. India Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 70. India Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2015-2020)
Table 71. India Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 72. India Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Prostate Cancer Nuclear Medicine Diagnostics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Prostate Cancer Nuclear Medicine Diagnostics Market Share (2019-2020)
Table 75. Central & South America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2015-2020)
Table 77. Central & South America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2015-2020)
Table 79. Blue Earth Diagnostics Company Details
Table 80. Blue Earth Diagnostics Business Overview
Table 81. Blue Earth Diagnostics Product
Table 82. Blue Earth Diagnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020) (Million US$)
Table 83. Blue Earth Diagnostics Recent Development
Table 84. PETNET Solutions Company Details
Table 85. PETNET Solutions Business Overview
Table 86. PETNET Solutions Product
Table 87. PETNET Solutions Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020) (Million US$)
Table 88. PETNET Solutions Recent Development
Table 89. Cardinal Health Company Details
Table 90. Cardinal Health Business Overview
Table 91. Cardinal Health Product
Table 92. Cardinal Health Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020) (Million US$)
Table 93. Cardinal Health Recent Development
Table 94. Lantheus Medical Imaging Company Details
Table 95. Lantheus Medical Imaging Business Overview
Table 96. Lantheus Medical Imaging Product
Table 97. Lantheus Medical Imaging Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020) (Million US$)
Table 98. Lantheus Medical Imaging Recent Development
Table 99. Jubilant Pharma Company Details
Table 100. Jubilant Pharma Business Overview
Table 101. Jubilant Pharma Product
Table 102. Jubilant Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020) (Million US$)
Table 103. Jubilant Pharma Recent Development
Table 104. NCM-USA Company Details
Table 105. NCM-USA Business Overview
Table 106. NCM-USA Product
Table 107. NCM-USA Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020) (Million US$)
Table 108. NCM-USA Recent Development
Table 109. Progenics Pharma Company Details
Table 110. Progenics Pharma Business Overview
Table 111. Progenics Pharma Product
Table 112. Progenics Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020) (Million US$)
Table 113. Progenics Pharma Recent Development
Table 114. Telix Pharma Business Overview
Table 115. Telix Pharma Product
Table 116. Telix Pharma Company Details
Table 117. Telix Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020) (Million US$)
Table 118. Telix Pharma Recent Development
Table 119. ImaginAb Company Details
Table 120. ImaginAb Business Overview
Table 121. ImaginAb Product
Table 122. ImaginAb Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020) (Million US$)
Table 123. ImaginAb Recent Development
Table 124. Theragnostics Company Details
Table 125. Theragnostics Business Overview
Table 126. Theragnostics Product
Table 127. Theragnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020) (Million US$)
Table 128. Theragnostics Recent Development
Table 129. Novartis Company Details
Table 130. Novartis Business Overview
Table 131. Novartis Product
Table 132. Novartis Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020) (Million US$)
Table 133. Novartis Recent Development
Table 134. Alliance Medical Company Details
Table 135. Alliance Medical Business Overview
Table 136. Alliance Medical Product
Table 137. Alliance Medical Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020) (Million US$)
Table 138. Alliance Medical Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. SPECT Features
Figure 3. PET Features
Figure 4. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Prostate Cancer Nuclear Medicine Diagnostics Report Years Considered
Figure 9. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Regions: 2020 VS 2026
Figure 11. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Players in 2019
Figure 14. Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Nuclear Medicine Diagnostics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Prostate Cancer Nuclear Medicine Diagnostics Revenue in 2019
Figure 16. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Blue Earth Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Blue Earth Diagnostics Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
Figure 25. PETNET Solutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. PETNET Solutions Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
Figure 27. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Cardinal Health Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
Figure 29. Lantheus Medical Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Lantheus Medical Imaging Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
Figure 31. Jubilant Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Jubilant Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
Figure 33. NCM-USA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. NCM-USA Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
Figure 35. Progenics Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Progenics Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
Figure 37. Telix Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Telix Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
Figure 39. ImaginAb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. ImaginAb Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
Figure 41. Theragnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Theragnostics Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
Figure 43. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Novartis Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
Figure 45. Alliance Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Alliance Medical Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs